In addition to neurodegenerative diseases, the inhibition of NF-kB activity by triptolide and celastrol has also been reported in studies on cerebral ischemia and spinal cord injury (Bai et al., 2016a; Huang et al., 2019; Liu D. D. et al., 2021). Here, NFKB1 is linked to Cerebral ischemia.